Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up

Strategic outsourcing utilizes external expertise (e.g., CROs, CDMOs) to accelerate the biopharma pipeline, integrating specialized workflows that drive efficiency from discovery through early clinical trials. This critical leveraging of partnership de-risks development for complex modalities like cell and gene therapies.

Register Free: https://www.pharmtech.com/pt_w/outsourcing

Event Overview:

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development. Forming strategic partnerships helps integrate specialized workflows, linking advanced therapy formulation and manufacturing to de-risk clinical progression. External contract research organization and contract development and manufacturing organization expertise are helping to accelerate complex modalities (e.g., cell and gene therapy, RNA, next-gen biologics, etc.) via optimized process development and integrated antibody discovery platforms. This episode of PharmTech Drug Digest will explore how this critical leveraging of partnership expertise speeds drug candidates from discovery to first-in-human clinical trials and beyond.

Key Learning Objectives:

• Understand how outsourcing drives biopharma efficiency and scale.
• Analyze how partnerships de-risk early clinical progression.
• Identify expertise accelerating complex modalities via development.
• Explore how leveraging partnership speeds discovery to clinical trials.

Who Should Attend:

• Strategic Alliances/Business Development Leaders
• R&D/Discovery/Preclinical Development Leads
• Manufacturing and Process Development Personnel
• Chief Operating Officers/Senior Management
• Clinical Development Directors/Managers

Register Free: https://www.pharmtech.com/pt_w/outsourcing